NCT04111419View on ClinicalTrials.gov

Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Atrial FibrillationHypertension
Interventions
DRUG

Amlodipine/Atorvastatin 5 Mg-20 Mg ORAL TABLET

amlodipine/atorvastatin (5/20mg tablet) once a day

DRUG

Amlodipine/Atorvastatin 5 Mg-10 Mg ORAL TABLET

amlodipine/atorvastatin (5/10mg tablet) once a day

DRUG

Allisartan Isoproxil

allisartan (240mg/tablet) once a day

Trial Locations (1)

200025

Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER